Aurobindo Pharma

BSE : 524804 | NSE : AUROPHARMA
Industry : Pharmaceuticals | ISIN : INE406A01037 | FreeFloat : 50.00% | FnO : Yes | LotSize : 650
Intellectual Capital (IC)26,988.83
Net Worth (NW)18,342.12
Intrinsic Worth (IW)45,330.95
Market Cap (MC)46,665.54
Economic Value Added-27.55
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)59.54%
IC Gross Margin (EBITDA/IC)20.17%
IC Net Margin (NPT/IC)12.17%
Knowledge Turnover (Sales/IC)0.87
Market to Intrinsic Value (MC/IW)1.03
As OfIntrinsic ValueMarket Price
30 Sep 2020Rs. 773.72Rs. 796.50
22 Jan 2021 - Rs. 923.80
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : NoSell10 DMA : Rs. 936.35AccumulateSell on Rallies
KB > 50% : Yes50 DMA : Rs. 898.96
0 < M2IV < 1 : NoVol-Price trend : Rising

Question 3 - Is this stock undervalued?

Question 2 - Does this business have significant knowledge assets?

Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.
Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Dec-17
C
4336.11
4369.16
1058.63
920.55
901.69
594.86
593.64
Mar-18
C
4049.09
4092.92
832.50
675.87
651.15
528.51
632.31
Jun-18
C
4250.27
4294.00
754.79
600.26
570.72
455.59
490.29
Sep-18
C
4751.40
4777.66
985.93
822.25
786.86
611.44
803.06
Dec-18
C
5269.67
5333.52
1127.76
964.64
916.99
712.21
538.78
Mar-19
C
5292.20
5324.47
1053.04
866.42
816.34
585.22
528.36
Jun-19
C
5444.60
5460.38
1154.19
913.33
863.44
635.68
645.76
Sep-19
C
5600.47
5621.09
1148.15
904.84
863.90
639.53
656.60
Dec-19
C
5895.00
5925.93
1225.41
975.28
938.17
705.31
816.53
Mar-20
C
6158.43
6191.02
1341.75
1109.34
1077.51
848.99
997.73
Jun-20
C
3419.70
3545.28
1090.41
970.62
960.19
714.68
711.55
Sep-20
C
6483.44
6537.19
1466.03
1208.69
1192.98
805.65
762.79
* C - Consolidated, S - Standalone